336 air samples were taken from 7 locations at 3 different heights over 3 months.
The test was carried out in practical and current activity conditions and involved three stages:
The testing of air samples reflected an 89% reduction in airborne bacteria CFU/m3, an 87% reduction in airborne fungi CFU/m3, and up to a 100% reduction in airborne Staphylococcus CFU/m3.
The hospital staff found the Novaerus air purification system to be: tolerable, easy to use and safe for patients and staff.
The Novaerus air purification system complemented existing measures such as washing the hands and surfaces and purifying the air to combat infections and does not require additional interventions to ensure that it functions without interruption.
About Us
Novaerus is on a mission to reduce indoor airborne pollutants that lead to infection, allergies, asthma, and odour.
The patented plasma nanotechnology used in Novaerus portable devices was invented in Ireland in 2006.
Novaerus Devices
Stay Connected to Novaerus
To keep up to date with all developments and for the latest research and scientifically proven results please follow us on LinkedIn, Facebook and Youtube.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.